Cargando…
The Role of the Bisphenol A in Diabetes and Obesity
Bisphenol A is a compound commonly found in products meant for daily use. It was one of the first compounds to be identified as an endocrine disruptor that was capable of disrupting the endocrine system and producing very similar effects to those of metabolic syndrome. It has recently gained popular...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230545/ https://www.ncbi.nlm.nih.gov/pubmed/34200822 http://dx.doi.org/10.3390/biomedicines9060666 |
_version_ | 1783713235645497344 |
---|---|
author | Pérez-Bermejo, Marcelino Mas-Pérez, Irene Murillo-Llorente, Maria Teresa |
author_facet | Pérez-Bermejo, Marcelino Mas-Pérez, Irene Murillo-Llorente, Maria Teresa |
author_sort | Pérez-Bermejo, Marcelino |
collection | PubMed |
description | Bisphenol A is a compound commonly found in products meant for daily use. It was one of the first compounds to be identified as an endocrine disruptor that was capable of disrupting the endocrine system and producing very similar effects to those of metabolic syndrome. It has recently gained popularity in the scientific arena as a risk factor for obesity and diabetes due to its ability to imitate natural oestrogens and bind to their receptors. The aim was to study the possible relationship between the Bisphenol A endocrine disruptor with diabetes and obesity. The analysis of the articles allows us to conclude that Bisphenol A is an additional risk factor to consider in the development of diabetes and obesity, since it is capable of stimulating the hypertrophy of adipocytes and altering the endocrine system by mimicking the effects of the oestrogen molecule, since epidemiological studies carried out have suggested that the same disruptions seen in experimental studies on animals can be found in humans; however, despite many countries having developed policies to limit exposure to this disruptor in their populations, there is a lack of international agreement. Understanding its relationship with obesity and diabetes will help to raise awareness in the population and adopt public health campaigns to prevent exposure—especially among young people—to these substances. |
format | Online Article Text |
id | pubmed-8230545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82305452021-06-26 The Role of the Bisphenol A in Diabetes and Obesity Pérez-Bermejo, Marcelino Mas-Pérez, Irene Murillo-Llorente, Maria Teresa Biomedicines Review Bisphenol A is a compound commonly found in products meant for daily use. It was one of the first compounds to be identified as an endocrine disruptor that was capable of disrupting the endocrine system and producing very similar effects to those of metabolic syndrome. It has recently gained popularity in the scientific arena as a risk factor for obesity and diabetes due to its ability to imitate natural oestrogens and bind to their receptors. The aim was to study the possible relationship between the Bisphenol A endocrine disruptor with diabetes and obesity. The analysis of the articles allows us to conclude that Bisphenol A is an additional risk factor to consider in the development of diabetes and obesity, since it is capable of stimulating the hypertrophy of adipocytes and altering the endocrine system by mimicking the effects of the oestrogen molecule, since epidemiological studies carried out have suggested that the same disruptions seen in experimental studies on animals can be found in humans; however, despite many countries having developed policies to limit exposure to this disruptor in their populations, there is a lack of international agreement. Understanding its relationship with obesity and diabetes will help to raise awareness in the population and adopt public health campaigns to prevent exposure—especially among young people—to these substances. MDPI 2021-06-10 /pmc/articles/PMC8230545/ /pubmed/34200822 http://dx.doi.org/10.3390/biomedicines9060666 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pérez-Bermejo, Marcelino Mas-Pérez, Irene Murillo-Llorente, Maria Teresa The Role of the Bisphenol A in Diabetes and Obesity |
title | The Role of the Bisphenol A in Diabetes and Obesity |
title_full | The Role of the Bisphenol A in Diabetes and Obesity |
title_fullStr | The Role of the Bisphenol A in Diabetes and Obesity |
title_full_unstemmed | The Role of the Bisphenol A in Diabetes and Obesity |
title_short | The Role of the Bisphenol A in Diabetes and Obesity |
title_sort | role of the bisphenol a in diabetes and obesity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230545/ https://www.ncbi.nlm.nih.gov/pubmed/34200822 http://dx.doi.org/10.3390/biomedicines9060666 |
work_keys_str_mv | AT perezbermejomarcelino theroleofthebisphenolaindiabetesandobesity AT masperezirene theroleofthebisphenolaindiabetesandobesity AT murillollorentemariateresa theroleofthebisphenolaindiabetesandobesity AT perezbermejomarcelino roleofthebisphenolaindiabetesandobesity AT masperezirene roleofthebisphenolaindiabetesandobesity AT murillollorentemariateresa roleofthebisphenolaindiabetesandobesity |